PURPOSE: Breast density is strongly related to breast cancer risk, but determinants of breast density in young women remain largely unknown. METHODS: Associations of reproductive and menstrual characteristics with breast density measured by magnetic resonance imaging were evaluated in a cross-sectional study of 176 healthy women, 25-29 years old, using linear mixed effects models. RESULTS: Parity was significantly inversely associated with breast density. In multivariable adjusted models that included non-reproductive variables, mean percent dense breast volume (%DBV) decreased from 20.5 % in nulliparous women to 16.0 % in parous women, while mean absolute dense breast volume (ADBV) decreased from 85.3 to 62.5 cm(3). Breast density also was significantly inversely associated with the age women started using hormonal contraceptives, whereas it was significantly positively associated with duration of hormonal contraceptive use. In adjusted models, mean %DBV decreased from 21.7 % in women who started using hormones at 12-17 years of age to 14.7 % in those who started using hormones at 22-28 years of age, while mean ADBV decreased from 86.2 to 53.7 cm(3). The age at which women started using hormonal contraceptives and duration of hormone use were inversely correlated, and mean %DBV increased from 15.8 % in women who used hormones for not more than 2.0 years to 22.0 % in women who used hormones for more than 8 years, while mean ADBV increased from 61.9 to 90.4 cm(3) over this interval. CONCLUSIONS: Breast density in young women is inversely associated with parity and the age women started using hormonal contraceptives but positively associated with duration of hormone use.
PURPOSE: Breast density is strongly related to breast cancer risk, but determinants of breast density in young women remain largely unknown. METHODS: Associations of reproductive and menstrual characteristics with breast density measured by magnetic resonance imaging were evaluated in a cross-sectional study of 176 healthy women, 25-29 years old, using linear mixed effects models. RESULTS: Parity was significantly inversely associated with breast density. In multivariable adjusted models that included non-reproductive variables, mean percent dense breast volume (%DBV) decreased from 20.5 % in nulliparous women to 16.0 % in parous women, while mean absolute dense breast volume (ADBV) decreased from 85.3 to 62.5 cm(3). Breast density also was significantly inversely associated with the age women started using hormonal contraceptives, whereas it was significantly positively associated with duration of hormonal contraceptive use. In adjusted models, mean %DBV decreased from 21.7 % in women who started using hormones at 12-17 years of age to 14.7 % in those who started using hormones at 22-28 years of age, while mean ADBV decreased from 86.2 to 53.7 cm(3). The age at which women started using hormonal contraceptives and duration of hormone use were inversely correlated, and mean %DBV increased from 15.8 % in women who used hormones for not more than 2.0 years to 22.0 % in women who used hormones for more than 8 years, while mean ADBV increased from 61.9 to 90.4 cm(3) over this interval. CONCLUSIONS: Breast density in young women is inversely associated with parity and the age women started using hormonal contraceptives but positively associated with duration of hormone use.
Authors: Mariëtte Lokate; Michiel G J Kallenberg; Nico Karssemeijer; Maurice A A J Van den Bosch; Petra H M Peeters; Carla H Van Gils Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-10-04 Impact factor: 4.254
Authors: Francesmary Modugno; Duyen L Ngo; Glenn O Allen; Lewis H Kuller; Roberta B Ness; Victor G Vogel; Joseph P Costantino; Jane A Cauley Journal: Breast Cancer Res Treat Date: 2005-12-16 Impact factor: 4.872
Authors: Parisa Tehranifar; Diane Reynolds; Julie Flom; Loralee Fulton; Yuyan Liao; Elizabeth Kudadjie-Gyamfi; Mary Beth Terry Journal: Cancer Causes Control Date: 2011-02-17 Impact factor: 2.506
Authors: Joanne F Dorgan; Robert P McMahon; Lisa Aronson Friedman; Linda Van Horn; Linda G Snetselaar; Peter O Kwiterovich; Ronald M Lauer; Norman L Lasser; Victor J Stevens; Alan Robson; Susan F Cooper; D Walt Chandler; Frank A Franklin; Bruce A Barton; Blossom H Patterson; Philip R Taylor; Arthur Schatzkin Journal: J Clin Endocrinol Metab Date: 2006-07-25 Impact factor: 5.958
Authors: Anne Marie Zaura Jukic; Clarice R Weinberg; Allen J Wilcox; D Robert McConnaughey; Paige Hornsby; Donna D Baird Journal: Am J Epidemiol Date: 2007-10-10 Impact factor: 4.897
Authors: Harriet Johansson; Sara Gandini; Bernardo Bonanni; Frederique Mariette; Aliana Guerrieri-Gonzaga; Davide Serrano; Enrico Cassano; Francesca Ramazzotto; Laura Baglietto; Maria Teresa Sandri; Andrea Decensi Journal: Breast Cancer Res Treat Date: 2007-04-28 Impact factor: 4.872
Authors: Linda Titus-Ernstoff; Anna N A Tosteson; Claudia Kasales; Julia Weiss; Martha Goodrich; Elizabeth E Hatch; Patricia A Carney Journal: Cancer Causes Control Date: 2006-12 Impact factor: 2.506
Authors: Seungyoun Jung; Olga Goloubeva; Nola Hylton; Catherine Klifa; Erin LeBlanc; John Shepherd; Linda Snetselaar; Linda Van Horn; Joanne F Dorgan Journal: Cancer Causes Control Date: 2018-05-25 Impact factor: 2.506
Authors: Jesse A Dorchak; Sifat Maria; Joseph L Guarinoni; Anette Duensing; Stella Somiari; Jane Cavanaugh; Brenda Deyarmin; Hai Hu; Joji Iida; Craig D Shriver; Paula A Witt-Enderby Journal: Horm Cancer Date: 2018-04-23 Impact factor: 3.869
Authors: Alexandra M Binder; Camila Corvalan; Ana Pereira; Antonia M Calafat; Xiaoyun Ye; John Shepherd; Karin B Michels Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-08-29 Impact factor: 4.254
Authors: Seungyoun Jung; Frank Z Stanczyk; Brian L Egleston; Linda G Snetselaar; Victor J Stevens; John A Shepherd; Linda Van Horn; Erin S LeBlanc; Kenneth Paris; Catherine Klifa; Joanne F Dorgan Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11-04 Impact factor: 4.254
Authors: Lusine Yaghjyan; Carmen Smotherman; John Heine; Graham A Colditz; Bernard Rosner; Rulla M Tamimi Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-12-03 Impact factor: 4.090
Authors: Seungyoun Jung; Olga Goloubeva; Catherine Klifa; Erin S LeBlanc; Linda G Snetselaar; Linda Van Horn; Joanne F Dorgan Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-19 Impact factor: 4.254
Authors: Seungyoun Jung; Brian L Egleston; D Walt Chandler; Linda Van Horn; Nola M Hylton; Catherine C Klifa; Norman L Lasser; Erin S LeBlanc; Kenneth Paris; John A Shepherd; Linda G Snetselaar; Frank Z Stanczyk; Victor J Stevens; Joanne F Dorgan Journal: Breast Cancer Res Date: 2015-06-04 Impact factor: 6.466
Authors: Kimberly A Bertrand; Heather J Baer; E John Orav; Catherine Klifa; John A Shepherd; Linda Van Horn; Linda Snetselaar; Victor J Stevens; Nola M Hylton; Joanne F Dorgan Journal: Breast Cancer Res Date: 2015-07-16 Impact factor: 6.466
Authors: Anya Burton; Gertraud Maskarinec; Beatriz Perez-Gomez; Celine Vachon; Hui Miao; Martín Lajous; Ruy López-Ridaura; Megan Rice; Ana Pereira; Maria Luisa Garmendia; Rulla M Tamimi; Kimberly Bertrand; Ava Kwong; Giske Ursin; Eunjung Lee; Samera A Qureshi; Huiyan Ma; Sarah Vinnicombe; Sue Moss; Steve Allen; Rose Ndumia; Sudhir Vinayak; Soo-Hwang Teo; Shivaani Mariapun; Farhana Fadzli; Beata Peplonska; Agnieszka Bukowska; Chisato Nagata; Jennifer Stone; John Hopper; Graham Giles; Vahit Ozmen; Mustafa Erkin Aribal; Joachim Schüz; Carla H Van Gils; Johanna O P Wanders; Reza Sirous; Mehri Sirous; John Hipwell; Jisun Kim; Jong Won Lee; Caroline Dickens; Mikael Hartman; Kee-Seng Chia; Christopher Scott; Anna M Chiarelli; Linda Linton; Marina Pollan; Anath Arzee Flugelman; Dorria Salem; Rasha Kamal; Norman Boyd; Isabel Dos-Santos-Silva; Valerie McCormack Journal: PLoS Med Date: 2017-06-30 Impact factor: 11.069